|
Press Releases |
|
 |
|
Monday, November 18, 2024 |
|
富士通など、世界初 スーパーコンピュータ「富岳」を用いてグラフ解析性能200 TeraTEPSを突破 |
理化学研究所、東京科学大学、株式会社フィックスターズ、日本電信電話株式会社、富士通株式会社による共同研究グループ※は、大規模グラフ解析に関するスーパーコンピュータの国際的な性能ランキングである「Graph500」のBFS(Breadth-First Search:幅優先探索)部門において、スーパーコンピュータ「富岳」(注1)の測定結果を大幅に向上させ、世界第1位を獲得しました。 more info >> |
|
Thursday, November 14, 2024 |
|
NEC、量子科学技術研究開発機構および核融合科学研究所から次期スーパーコンピュータシステムを受注 |
NECは、国立研究開発法人量子科学技術研究開発機構(所在地:千葉県千葉市、理事長:小安 重夫、以下量研)および大学共同利用機関法人自然科学研究機構核融合科学研究所(所在地:岐阜県土岐市、所長:吉田 善章、以下核融合研)から次期スーパーコンピュータシステムを受注しました。量研および核融合研は本システムを量研の六ヶ所フュージョンエネルギー研究所(注1)に設置し、2025年7月から運用開始する予定です。 more info >> |
|
Wednesday, November 13, 2024 |
|
Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program |
NEC X, the Silicon Valley venture studio backed by NEC's portfolio of advanced technologies and global businesses, today announced a new investment in General Prognostics Inc. more info >> |
|
NEC receives order for next-generation supercomputer system from Japan's National Institutes for Quantum Science and Technology and National Institute for Fusion Science |
NEC Corporation (NEC; TSE: 6701) has received an order for a next-generation supercomputer system from Japan's National Institutes for Quantum Science and Technology (QST). more info >> |
|
Tuesday, November 12, 2024 |
|
NEC participates in COP29 climate change conference |
NEC Corporation is participating in the 29th Conference of the Parties (COP29) to the United Nations Framework Convention on Climate Change (UNFCCC), held in Azerbaijan from November 11 to 22, 2024 with a keynote speech in the UGIH Pavilion, the host organization of the conference, and a seminar organized by Japan's Ministry of the Environment and the Ministry of Internal Affairs and Communications in the Japan Pavilion. more info >> |
|
Friday, November 8, 2024 |
|
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 |
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE: 6701), a leader in IT, network and AI technologies, today announced 24.1 month median follow-up data from the ongoing randomized Phase I trial of TG4050 in the adjuvant treatment of head and neck cancers. more info >> |
|
Thursday, November 7, 2024 |
|
NEC and NEC Bio publish foundational work on T Cell Receptor engineering using proprietary generative AI at the Society for Immunotherapy of Cancer annual meeting |
Utilizing proprietary generative AI technology, NEC Bio has successfully modified T cell receptors (TCRs) to increase their efficacy. more info >> |
|
Monday, October 28, 2024 |
|
NEC launches new end to end private 5G solution with Cisco |
NEC Corporation, a leader in the integration of IT and network technologies, is joining forces with Cisco to deliver a new private 5G network solution to their customers. more info >> |
|
Friday, October 25, 2024 |
|
Joint proposal by NTT, KDDI, Fujitsu, NEC, and Rakuten Mobile adopted as Japan's Ministry of Internal Affairs and Communications/NICT's "Innovative ICT Fund Projects for Beyond 5G/6G" for social implementation and overseas expansion oriented strategic program (common infrastructure technology establishment) |
NTT Corporation, KDDI Corporation, KDDI Research, Inc. participating in research and development as a research collaborator, Fujitsu Limited, NEC Corporation, and Rakuten Mobile, Inc. were selected by the Japan-based National Institute of Information and Communications Technology to conduct newly commissioned research in FY 2024 pertaining to a strategic program oriented toward social implementation and overseas expansion (common infrastructure technology establishment) for the Innovative ICT Fund Projects for Beyond 5G/6G. more info >> |
|
Tuesday, October 22, 2024 |
|
NTT、KDDI、富士通、NEC、楽天モバイルによる共同提案が総務省/NICTの「革新的情報通信技術(Beyond 5G(6G))基金事業」社会実装・海外展開志向型戦略的プログラム(共通基盤技術確立型)に採択 |
日本電信電話株式会社(本社:東京都千代田区、代表取締役社長:島田 明、以下「NTT」)、KDDI株式会社(本社:東京都千代田区、代表取締役社長CEO:髙橋 誠、以下「KDDI」。研究実施協力者として株式会社KDDI総合研究所(本社:埼玉県ふじみ野市、代表取締役所長:中村 元)が研究開発に参画)、富士通株式会社(本店:神奈川県川崎市、代表取締役社長:時田 隆仁、以下「富士通」)、日本電気株式会社(本社:東京都港区、取締役 代表執行役社長 兼 CEO:森田 隆之、以下「NEC」)、楽天モバイル株式会社(本社:東京都世田谷区、代表取締役社長:矢澤 俊介、以下「楽天モバイル」)は、国立研究開発法人情報通信研究機構(以下「NICT」)が公募した革新的情報通信技術(Beyond 5G(6G))基金事業の社会実装・海外展開志向型戦略的プログラム(共通基盤技術確立型)に係る令和6年度新規委託研究の実施企業に採択されました。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
How Do AI Workflow Automations Work?
Aug 16, 2025 00:00 HKT/SGT
|
|
|
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Aug 15, 2025 23:18 HKT/SGT
|
|
|
Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million
Aug 15, 2025 23:17 HKT/SGT
|
|
|
The 35th Food Expo opens today
Aug 15, 2025 23:16 HKT/SGT
|
|
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 15, 2025 23:06 HKT/SGT
|
|
|
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Aug 15, 2025 20:15 HKT/SGT
|
|
|
艾曲莫德入選《2025 ACG臨床指南:成人潰瘍性結腸炎》,獲強烈推薦用於中重度潰瘍性結腸炎的誘導緩解及維持緩解治療
Aug 15, 2025 20:07 HKT/SGT
|
|
|
艾曲莫德入选《2025 ACG临床指南:成人溃疡性结肠炎》,获强烈推荐用于中重度溃疡性结肠炎的诱导缓解及维持缓解治疗
Aug 15, 2025 19:56 HKT/SGT
|
|
|
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively
Aug 15, 2025 19:11 HKT/SGT
|
|
|
業聚醫療2025年中期業績收入及純利雙雙增長 分別達8,360萬美元及1,980萬美元
Aug 15, 2025 18:53 HKT/SGT
|
|
|
业聚医疗2025年中期业绩收入及纯利双双增长 分别达8,360万美元及1,980万美元
Aug 15, 2025 18:10 HKT/SGT
|
|
|
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements
Aug 15, 2025 18:00 HKT/SGT
|
|
|
廣發証券榮膺國家數據管理能力成熟度(DCMM)最高等級認証
Aug 15, 2025 17:28 HKT/SGT
|
|
|
米国株式アクティブ残高10年連続世界No.1ティー・ロウ・プライス[1] 日本法人が既存追加型株式投資信託に「毎月決算・予想分配金提示型」ファンドを新規設定
Aug 15, 2025 17:15: JST
|
|
|
广发证券荣膺国家数据管理能力成熟度(DCMM)最高等级认证
Aug 15, 2025 17:12 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|